Thrilled our study of chemo-immunotherapy in MIBC was published in JCO this week! My @ASCO @AACR #Vail workshop protocol and a great collaboration between @UNC_Lineberger and @DukeGUCancer - thanks to all for the tremendous support along the way, most especially @MattMilowsky
Inimitable @TracyLRoseMD @UNCUroOnc @UNCurology @UNC_Lineberger with @MRHarrisonMD & outstanding colleagues @DukeGUCancer publishes in @JCO_ASCO Ph2 neoadjuvant chemo-IO with promising 56% <pT2 rate. Continued progress in #BladderCancer. @BladderCancerUS ascopubs.org/doi/abs/10.120…View quoted post on X